Filing Details
- Accession Number:
- 0001125345-20-000133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-10 16:44:55
- Reporting Period:
- 2020-09-09
- Accepted Time:
- 2020-09-10 16:44:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1567045 | Kenneth Galbraith | 9704 Medical Center Drive Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-09 | 13,849 | $16.00 | 13,849 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-09 | 13,849 | $27.11 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-09-09 | 6,924 | $20.15 | 6,924 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-09 | 6,924 | $27.11 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-09-09 | 13,849 | $0.00 | 13,849 | $16.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-09-09 | 6,924 | $0.00 | 6,924 | $20.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-10-09 | No | 4 | M | Direct | |
| 0 | 2024-06-05 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $26.96 to $27.22. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staffof the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- 33.33% of the option became exercisable on October 9, 2014, and the remainder of the option vested in substantially equal annual installments.
- The option vested and became exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.
Billionaire Hedge Funds
